ARA-290 studies
50 journal papers mention ARA-290 in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.
Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether ARA-290 is safe, effective or approved for any use.
- Papers
- 50
- 42 articles, 8 reviews
- Earliest paper
- 2010
- Most papers in 2026 (9)
- Open access
- 74%
- free to read somewhere
- Reviews
- 16%
- of all papers listed
What kind of studies
Of 37 papers in PubMed that mention ARA-290 in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.
- Randomized controlled trials3
- Other clinical trials1
- Meta-analyses and systematic reviews2
- Other reviews6
- Case reports1
- Animal studies only9
- Studies in humans21
Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).
Registered clinical studies
Studies on ClinicalTrials.gov that mention ARA-290 in their intervention details. A registration says a study is planned or running, not what it found.
- Registered
- 4
- Completed
- 2
- Ongoing or planned
- 0
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 0
- The Use of ARA290 for the Treatment of Diabetic Macular Oedema
NCT06626971TerminatedPhase 2started 2016-04
- Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis
NCT02039687CompletedPhase 2started 2014-01
- ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
NCT01933529Status unknownPhase 2started 2013-10
- Cognitive and Neural Effects of ARA290
NCT02070783CompletedPhase 1 / Phase 2started 2012-02
The five most recently updated studies. See all 4 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.
Papers per year
2010 to 2026, peak 9 papers in a year. The latest year may still be incomplete.
Where it is published
- Molecular Medicine4 papers
- Transplantation3 papers
- Bone Reports3 papers
- Research Results in Pharmacology3 papers
- Journal of Vascular Surgery2 papers
The papers
Most citedName in the title
- ARA 290 for treatment of small fiber neuropathy in sarcoidosis
Monique van Velzen, Lara Rosaline Heij, Marieke Niesters et al. · Expert Opinion on Investigational Drugs · 2014
Review43 citations
LatestName in title or abstract
- Regenerative peptides for inferior alveolar nerve injury: a narrative review
Scott H. Froum, Nathan E. Estrin, Gianna Pico et al. · Frontiers in Dental Medicine · 2026
ReviewOpen access · CC BYRead the open copy →
- Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases
Scott H. Froum, Nathan E. Estrin, Gianna Pico et al. · Frontiers in Oral Health · 2026
Case reportOpen access · CC BYRead the open copy →
- Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management
Choopong Luansritisakul, Monping Chiang, Stacey L. Burns et al. · Current Pain and Headache Reports · 2026
Review
- Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy
Yujin Sun, Bo Song, Yonglei Zhang et al. · Frontiers in Neurology · 2026
ReviewOpen access · CC BYRead the open copy →
- The time to develop treatments for diabetic neuropathy
Marc Rendell · Expert Opinion on Investigational Drugs · 2021
Systematic review10 citations
- Managing fatigue in sarcoidosis – A systematic review of the evidence
Christopher Atkins, Andrew M. Wilson · Chronic Respiratory Disease · 2016
Systematic reviewOpen access40 citationsRead the open copy →
- Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin
Massimo Collino, Christoph Thiemermann, Anthony Cerami et al. · Pharmacology & Therapeutics · 2015
ReviewOpen access · CC BY-NC-ND92 citationsRead the open copy →
- ARA 290 for treatment of small fiber neuropathy in sarcoidosis
Monique van Velzen, Lara Rosaline Heij, Marieke Niesters et al. · Expert Opinion on Investigational Drugs · 2014
Review43 citations
Each list shows up to 40 papers.See all 50 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.